Home » Eliquis Approved in Japan for the Prevention of Stroke and Systemic Embolism
Eliquis Approved in Japan for the Prevention of Stroke and Systemic Embolism
Bristol-Myers Squibb and Pfizer announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Eliquis (apixaban) for the prevention of ischemic stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF).
DailyFinance
DailyFinance
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May